A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD)

Condition:   Alzheimer Disease Intervention:   Drug: Gantenerumab Sponsor:   Hoffmann-La Roche Not yet recruiting

Source: ClinicalTrials.gov - April 9, 2020 Category: Research Source Type: clinical trials